Nothing Special   »   [go: up one dir, main page]

EA199900253A1 - Ptx-чувствительные g-протеины, их получение и применение - Google Patents

Ptx-чувствительные g-протеины, их получение и применение

Info

Publication number
EA199900253A1
EA199900253A1 EA199900253A EA199900253A EA199900253A1 EA 199900253 A1 EA199900253 A1 EA 199900253A1 EA 199900253 A EA199900253 A EA 199900253A EA 199900253 A EA199900253 A EA 199900253A EA 199900253 A1 EA199900253 A1 EA 199900253A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
ptx
proteins
sensitive
receiving
Prior art date
Application number
EA199900253A
Other languages
English (en)
Inventor
Винфрид Зифферт
Original Assignee
Винфрид Зифферт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Винфрид Зифферт filed Critical Винфрид Зифферт
Publication of EA199900253A1 publication Critical patent/EA199900253A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)

Abstract

В заявке описана β3-субъединица человеческого G-протеина, которая включает не более шести мотивов WD-повтора.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900253A 1996-09-13 1997-08-29 Ptx-чувствительные g-протеины, их получение и применение EA199900253A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
EA199900253A1 true EA199900253A1 (ru) 1999-10-28

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900253A EA199900253A1 (ru) 1996-09-13 1997-08-29 Ptx-чувствительные g-протеины, их получение и применение

Country Status (22)

Country Link
US (1) US6251853B1 (ru)
EP (1) EP0931145A1 (ru)
JP (1) JP2001501811A (ru)
KR (1) KR20000036058A (ru)
CN (1) CN1230222A (ru)
AU (1) AU4619297A (ru)
BG (1) BG103238A (ru)
BR (1) BR9711475A (ru)
CA (1) CA2265467A1 (ru)
CZ (1) CZ73499A3 (ru)
DE (1) DE19637518A1 (ru)
EA (1) EA199900253A1 (ru)
EE (1) EE9900092A (ru)
HU (1) HUP9904110A3 (ru)
IL (1) IL128746A0 (ru)
IS (1) IS4987A (ru)
NO (1) NO991227L (ru)
PL (1) PL332417A1 (ru)
SK (1) SK34099A3 (ru)
TR (1) TR199900500T2 (ru)
WO (1) WO1998011212A1 (ru)
ZA (1) ZA978220B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
WO1999058669A1 (en) * 1998-05-11 1999-11-18 Axys Pharmaceuticals, Inc. Rhoh genes and their uses
WO2000015785A2 (de) * 1998-09-10 2000-03-23 Winfried Siffert GENVERÄNDERUNG IM GEN FÜR DIE Gβ3-UNTEREINHEIT DES HUMANEN G-PROTEINS
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
CA2399141A1 (en) * 2000-02-03 2001-08-09 Snip Biotech Gmbh & Co. Kg Use of a mutation in the gene for the .beta.3-subunit of human g-protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
BR9711475A (pt) 1999-08-24
BG103238A (bg) 2000-06-30
PL332417A1 (en) 1999-09-13
IS4987A (is) 1999-02-26
NO991227D0 (no) 1999-03-12
AU4619297A (en) 1998-04-02
TR199900500T2 (xx) 1999-06-21
JP2001501811A (ja) 2001-02-13
KR20000036058A (ko) 2000-06-26
CZ73499A3 (cs) 1999-07-14
HUP9904110A2 (en) 2000-07-28
US6251853B1 (en) 2001-06-26
HUP9904110A3 (en) 2001-09-28
WO1998011212A1 (de) 1998-03-19
CN1230222A (zh) 1999-09-29
DE19637518A1 (de) 1998-04-09
SK34099A3 (en) 2000-05-16
EE9900092A (et) 1999-10-15
IL128746A0 (en) 2000-01-31
EP0931145A1 (de) 1999-07-28
NO991227L (no) 1999-03-12
ZA978220B (en) 1999-03-12
CA2265467A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
BR9703128A (pt) Classificador com argolas
ATE286907T1 (de) Cytokinin-designiertes lerk-5
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
DK0825867T3 (da) N,O-carboxymethylchitosan til forhindring af operationssammenvoksninger
NO991818D0 (no) FremgangsmÕte for mottaking, samt mottaker
BR9706459B1 (pt) gerador termoelÉtrico submarino.
FR2701538B3 (fr) Gyrophare.
DE58905395D1 (de) Galvanisches Primärelement.
IT1295970B1 (it) Metodo di sequenziazione di oggetti postali.
EA199900253A1 (ru) Ptx-чувствительные g-протеины, их получение и применение
ID16192A (id) Proses pembuatan asam-asam .alpha., beta-karboksilat organik tak jenuh
FR2702900B1 (fr) Générateur de Marx.
DE69938130D1 (de) Neue peptide
EA200000208A1 (ru) Иммуномодулятор с антимикробной и антимикобактериальной активностью, способ его получения и лекарственный препарат для лечения микобактериозов, хронических неспецифических заболеваний легких, заболеваний, передающихся половым путем, и иммунодефицита на их основе
BR9806113B1 (pt) regulador de gerador.
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
MX9200835A (es) Aparato sin membrana generador de gas cloro.
DZ2034A1 (fr) Sel de pyrrolydinyl-methyl-indole.
EA200100440A1 (ru) Ген prv-1 и его применение
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ATE438660T1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
FR2704017B1 (fr) Agrafe de maintien.
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза
Rančić Environmental protection in the contemporary system of education
ECSP982804A (es) Beta- lipotropina y usos de la misma